|
|
||||||||
From the Department of Obstetrics and Gynecology, Duke University Medical Center, Southeastern Regional Trophoblastic Disease Center, Durham, NC 27706
Abstract
A review of the history of trophoblastic disease and its treatment and the assimilated experience of one of the regional centers is presented. The advent of single-agent chemotherapy raised the remission rate of nonmetastatic disease to 93% and of the metastatic form to 74%. Several new vigorous, initial therapeutic methods have been introduced at the SE Regional Center for patients who had developed resistance to all forms of single-agent therapy and for those with poor prognosis, as based upon prolonged duration of disease, high initial HCG titer, and cerebral or hepatic metastases.
This article has been cited by other articles:
![]() |
Thyrotoxicosis of a rare aetiology Postgrad. Med. J., December 1, 2000; 76(902): 802c - 802. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |